Speakers

Meet our workshop speakers and discover their research and contributions to clinical trials for new-onset T1D.

Matthias von Herrath

Vice President, Novo Nordisk

Prof. Helen Colhoun

Professor Helen Colhoun (MB BCh BAO, MD, MFMHM FRCP (Ed)) is a Professor (AXA Chair) of Medical Info, Professor Helen Colhoun (MB BCh BAO, MD, MFMHM FRCP (Ed)) is a Professor (AXA Chair) of Medical Info

Chantal Mathieu

Professor, KULeuven

Tadej Battelino

Profressor, University Medical Center Ljubljana

Joshua A. Vieth, PhD

Senior Director, Research, Breakthrough T1D

Stephen Karpen

Senior Director, Regulatory Affairs, Breakthrough T1D

Ulf Hannelius

President & CEO, Diamyd Medical

Kuanysh Kabytaev

Research Assistant Professor, Director Diabetes Diagnostic Lab, University of Missouri

Jeffrey Siegel

Office Director, FDA

Julie Heverly

Vice President, Time in Range Coalition and Patient Advocacy, The diaTribe Foundation

Hailey Davenport

Senior Project Manager, Critical Path Institute

Joseph Hedrick

Executive Director, Type 1 Diabetes Consortium, Critical Path Institute

Carla Greenbaum

Director Center for Interventional Immunology, Benaroya Research Institute

Teresa Quattrin

Associate Dean Research Integration, Jacobs School of Medicine and Biomedical Sciences - University at Buffalo

Elisabeth Niemoeller

Therapeutic Area Head DCVM, Sanofi

Carmella Evans-Molina, MD, PhD

Eli Lilly Professor of Pediatric Diabetes, Indiana University School of Medicine

Prof. Colin Mark Dayan

Professor of Clinical Diabetes and Metabolism, Cardiff University

Kimberly Collins

Senior Quantitative Medicine Scientist, Critical Path Institute

Christoph Tasto

Statistical Project Leader, Sanofi

Lauren Wood Heickman, MD

Medical Officer, Division of Diabetes, Lipid Disorders, and Obesity, FDA

Lynn Starr

Chief Global Advocacy Officer, Breakthrough T1D

John Sharretts, MD

Director, Division of Diabetes, Lipid Disorders, and Obesity, Office of New Drugs, Center for Drug Evaluation and Research, FDA

Laura Knecht, MD

Group Principal Clinical Research Director, Sanofi

Justin Penzenstadler, PharmD

Clinical Team Leader, Division of Diabetes, Lipid Disorders, and Obesity, FDA

Jason Gaglia, MD, MMSc

Assistant Investigator, Joslin Diabetes Center